Origin House Provides Corporate Update

 In Cresco, News Release

Ottawa, Canada – July 2, 2019 – CannaRoyalty Corp. d/b/a Origin House (CSE: OH) (OTCQX: ORHOF) (“Origin House” or the “Company“), a North American cannabis products and brands company, provided an update regarding its pending transaction with Cresco Labs Inc. (“Cresco Labs”), the replacement of its debt facility and other business updates.

Update on U.S. Antitrust Review

As recently disclosed, in connection with the previously announced plan of arrangement pursuant to which Cresco Labs will acquire all of the issued and outstanding shares of Origin House (the “Arrangement”), the Company and Cresco Labs received requests for additional information (“Second Requests”) from the United States Department of Justice Antitrust Division (the “DOJ”) pursuant to the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR Act”). The issuance of Second Requests is a statutory tool used by the DOJ to investigate pending transactions.

The effect of the Second Requests is to extend the waiting period imposed by the HSR Act until 30 days after both Origin House and Cresco Labs have substantially complied with their respective Second Requests, unless that period is extended voluntarily by the parties or terminated sooner by the DOJ. Origin House and Cresco Labs are cooperating fully with the DOJ’s investigation, are in active discussions with the DOJ regarding the Second Requests, have allocated the resources required to expeditiously and completely respond to the Second Requests, and look forward to completing the Arrangement.

The Origin House and Cresco Labs businesses are highly complementary, and areas of overlap are minimal and not material to either the strategic or financial rationale of the pending acquisition. Both companies are confident that the regulatory approvals will be obtained, and the Arrangement will proceed as planned.

Replacement of C$12 Million Debt Facility

The Company announced that it has entered into a binding term sheet agreement (the “Term Sheet”) with Opaskwayak Cree Nation (“OCN”) for a C$12 million debt financing (the “Financing”). Proceeds from the Financing are expected to be used by Origin House for the construction and expansion of its premium craft cannabis production facilities in Sonoma County – Cub City and FloraCal, for costs related to closing of the Arrangement, and for general corporate purposes. The Financing replaces the Company’s previously announced $12 million debt facility with a subsidiary of Sprott Inc. (“Sprott“), which has now been terminated.

$3,500,000 of the Financing has already been funded with the balance expected to be advanced in the coming days. The Financing is subject to a 5% commitment fee, bears interest at a rate of 10% per annum on the amount advanced and matures on December 31, 2019. The advances are currently evidenced by a promissory note which will be replaced by definitive loan and security documentation once such documentation is finalized.

The Company’s consolidated cash balance as of the end of the first quarter of 2019 was C$39.3 million.

Grant of Subordinate Voting Shares

The Company also announced that, as approved by shareholders at the Company’s special meeting of shareholders held on June 11, 2019, the Company has now amended its articles to create an unlimited number of subordinate voting shares. Each subordinate voting share is convertible into 0.000001 of one Common Share of the Company. As set out in the Company’s management information circular dated May 13, 2019, the Company intends to issue the subordinate voting shares to officers of the Company who are not resident in the United States.

On June 28, 2019, Origin House issued to Marc Lustig, Chairman and CEO of the Company, 50,000,000 subordinate voting shares as a share-based award for his past services at a deemed issue price of C$0.00000821 per subordinate voting share (an aggregate deemed issue price of C$410.50). The subordinate voting shares issued to Mr. Lustig are convertible into, in the aggregate, 50 Common Shares of the Company.

In accordance with Canadian Securities Exchange requirements, the securities issued are subject to a four month hold period.

About Origin House

Origin House is a growing cannabis brands and distribution company operating across key markets in the U.S. and Canada, with a strategic focus on becoming a preeminent global house of cannabis brands. Origin House’s foundation is in California, the world’s largest regulated cannabis market, where it delivers over 130 branded cannabis products from 50+ brands to the majority of licensed dispensaries. Origin House’s brand development platform is operated out of five licensed facilities located across California, and provides distribution, manufacturing, cultivation and marketing services for its brand partners. Origin House is actively developing infrastructure to support the proliferation of its brands internationally, initially through its acquisition of Canadian retailer 180 Smoke. Origin House’s shares trade on the CSE under the symbol “OH” and on the OTCQX under the symbol “ORHOF”. Origin House is the registered business name of CannaRoyalty Corp. For more information, visit www.originhouse.com.

For further inquiries, please contact:

General
info@originhouse.com
1-844-556-5070

Jonathan Ross
LodeRock Advisors Inc., Origin House Investor Relations
416-283-0178
jon.ross@loderockadvisors.com

Media
Priyam Chakraborty
Communications Manager, Origin House
pchakraborty@originhouse.com
647-232-9287

Forward-looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Origin House’s periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward- looking statements.
Forward-looking statements may include, without limitation, statements with respect to the terms of the Financing (including, without limitation, the use of proceeds, timing and amount of advances, and the forms and timing of documentation), statements relating to the terms of the Arrangement (including, without limitation, the terms, timing, closing and conditions thereof), timing to respond to the Second Request, and the effect of the Second Request on the timing of the Arrangement.
Although the Company has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: investing in target companies or projects that are engaged in activities currently considered illegal under US federal law; changes in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindered market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry; and regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward- looking statements in this news release are made as of the date of this release. The Company disclaims any intention or obligation to update or revise such information, except as required by applicable law, and the Company does not assume any liability for disclosure relating to any other company mentioned herein.